Centrum Medyczne Enel-Med S.A.
ISIN: PLENLMD00017 | Ticker: ENE | LEI: 259400C3GI6IVAOIM347
Country: Poland
Centrum Medyczne Enel-Med SA is a Poland-based company providing medical services.
The ENEL-MED Medical Centre is a Polish family company the founder of which is Adam Rozwadowski - from the very beginning the owner and the Management Board President of the company.
The main objective of the company has always been continuous development, increasing of potential, establishment of new facilities, and introduction of new technologies and methods.
1993
Served areaPoland
HeadquartersSłomińskiego 19/524, 00-195 Warszawa – Poland
| Line item in (pln) | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | 393,392,000.00 | N/A | 437,687,000.00 | 432,151,000.00 |
| Noncurrent Assets | N/A | 346,955,000.00 | N/A | 332,691,000.00 | 372,451,000.00 |
| Property Plant And Equipment | N/A | 126,495,000.00 | N/A | 133,313,000.00 | 151,581,000.00 |
| Goodwill | N/A | 766,000.00 | N/A | 766,000.00 | 2,958,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 7,193,000.00 | N/A | 14,139,000.00 | 17,402,000.00 |
| Investment Accounted For Using Equity Method | N/A | 1,000.00 | N/A | 1,000.00 | 1,000.00 |
| Noncurrent Prepayments And Noncurrent Accrued Income Other Than Noncurrent Contract Assets | N/A | N/A | N/A | 962,000.00 | 1,884,000.00 |
| Deferred Tax Assets | N/A | N/A | N/A | 0.00 | 3,426,000.00 |
| Other Noncurrent Financial Assets | N/A | 5,196,000.00 | N/A | 5,644,000.00 | 6,219,000.00 |
| Current Assets | N/A | 46,437,000.00 | N/A | 104,996,000.00 | 59,700,000.00 |
| Inventories | N/A | 4,683,000.00 | N/A | 3,012,000.00 | 3,529,000.00 |
| Trade And Other Current Receivables | N/A | 20,260,000.00 | N/A | 23,332,000.00 | 29,458,000.00 |
| Current Tax Assets Current | N/A | 919,000.00 | N/A | 898,000.00 | 245,000.00 |
| Other Current Financial Assets | N/A | 1,512,000.00 | N/A | 1,571,000.00 | 1,614,000.00 |
| Current Financial Assets At Fair Value Through Other Comprehensive Income | N/A | 1,223,000.00 | N/A | 1,414,000.00 | 1,402,000.00 |
| Cash and cash equivalents | 8,287,000.00 | 17,840,000.00 | 17,840,000.00 | 74,769,000.00 | 23,452,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 46,437,000.00 | N/A | 104,996,000.00 | 59,700,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | N/A | 0.00 | 0.00 |
| Equity And Liabilities | N/A | 393,392,000.00 | N/A | 437,687,000.00 | 432,151,000.00 |
| Equity | 102,307,000.00 | 98,909,000.00 | 98,079,000.00 | 175,603,000.00 | 152,033,000.00 |
| Issued Capital | N/A | 23,567,000.00 | N/A | 28,280,000.00 | 28,280,000.00 |
| Retained Earnings | N/A | 50,493,000.00 | N/A | 48,254,000.00 | 24,696,000.00 |
| Share Premium | N/A | 24,886,000.00 | N/A | 98,915,000.00 | 98,915,000.00 |
| Other Reserves | N/A | -36,000.00 | N/A | 155,000.00 | 144,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 98,910,000.00 | N/A | 175,604,000.00 | 152,035,000.00 |
| Noncontrolling Interests | N/A | -1,000.00 | N/A | -1,000.00 | -2,000.00 |
| Liabilities | N/A | 294,483,000.00 | N/A | 262,084,000.00 | 280,118,000.00 |
| Noncurrent Liabilities | N/A | 207,293,000.00 | N/A | 167,914,000.00 | 175,645,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 521,000.00 | N/A | 425,000.00 | 443,000.00 |
| Noncurrent Payables | N/A | 6,600,000.00 | N/A | 6,767,000.00 | 5,863,000.00 |
| Deferred Tax Liabilities | N/A | 1,407,000.00 | N/A | 994,000.00 | 0.00 |
| Noncurrent Portion Of Noncurrent Loans Received | N/A | 11,041,000.00 | N/A | 4,129,000.00 | 1,302,000.00 |
| Current Liabilities | N/A | 87,190,000.00 | N/A | 94,170,000.00 | 104,473,000.00 |
| Current Provisions For Employee Benefits | N/A | 905,000.00 | N/A | 825,000.00 | 1,068,000.00 |
| Trade And Other Current Payables | N/A | 40,270,000.00 | N/A | 48,146,000.00 | 54,644,000.00 |
| Current Tax Liabilities Current | N/A | 0.00 | N/A | 0.00 | 3,000.00 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 87,190,000.00 | N/A | 94,170,000.00 | 104,473,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | N/A | 0.00 | 0.00 |
| Current Loans Received And Current Portion Of Noncurrent Loans Received | N/A | 12,862,000.00 | N/A | 7,201,000.00 | 7,352,000.00 |
| Line item in (pln) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 399,798,000.00 | 441,144,000.00 | 494,904,000.00 |
| Other Income | 7,635,000.00 | 7,818,000.00 | 8,308,000.00 |
| Profit Loss From Operating Activities | 15,944,000.00 | 4,681,000.00 | -20,841,000.00 |
| Finance Income | 302,000.00 | 753,000.00 | 1,550,000.00 |
| Finance Costs | 20,725,000.00 | 5,338,000.00 | 8,651,000.00 |
| Profit Loss Before Tax | -4,479,000.00 | 96,000.00 | -27,942,000.00 |
| Income Tax Expense Continuing Operations | -1,084,000.00 | 1,506,000.00 | -4,384,000.00 |
| Profit Loss From Continuing Operations | -3,395,000.00 | -1,410,000.00 | -23,558,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | 0.00 |
| Profit (loss) | -3,395,000.00 | -1,410,000.00 | -23,558,000.00 |
| Profit Loss Attributable To Owners Of Parent | -3,395,000.00 | -1,410,000.00 | -23,558,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 0.00 | 0.00 | 0.00 |
| Line item in (pln) | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | -3,395,000.00 | N/A | -1,410,000.00 | N/A | -23,558,000.00 |
| Adjustments For Reconcile Profit Loss | 81,807,000.00 | N/A | 68,852,000.00 | N/A | 67,997,000.00 |
| Adjustments For Decrease Increase In Inventories | -976,000.00 | N/A | 1,670,000.00 | N/A | -384,000.00 |
| Adjustments For Depreciation And Amortisation Expense | 56,939,000.00 | N/A | 57,467,000.00 | N/A | 62,119,000.00 |
| Adjustments For Provisions | -11,000.00 | N/A | -176,000.00 | N/A | 260,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | 12,200,000.00 | N/A | -943,000.00 | N/A | 1,983,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 4,210,000.00 | N/A | 622,000.00 | N/A | 3,331,000.00 |
| Adjustments For Reconcile Profit Loss | 81,807,000.00 | N/A | 68,852,000.00 | N/A | 67,997,000.00 |
| Cash Flows From Used In Operations | 77,328,000.00 | N/A | 68,948,000.00 | N/A | 40,055,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 2,962,000.00 | N/A | 1,777,000.00 | N/A | 7,000.00 |
| Cash Flows From Used In Operating Activities | 74,366,000.00 | N/A | 67,171,000.00 | N/A | 40,048,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | 0.00 | N/A | 2,528,000.00 |
| Interest Received Classified As Investing Activities | N/A | N/A | 0.00 | N/A | 98,000.00 |
| Other Inflows Outflows Of Cash Classified As Investing Activities | N/A | N/A | 0.00 | N/A | 60,000.00 |
| Cash Flows From Used In Investing Activities | -10,880,000.00 | N/A | -38,100,000.00 | N/A | -48,252,000.00 |
| Proceeds From Issuing Shares | 0.00 | N/A | 78,743,000.00 | N/A | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | 5,100,000.00 | N/A | 0.00 | N/A | 3,949,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 20,478,000.00 | N/A | 12,863,000.00 | N/A | 7,241,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 31,916,000.00 | N/A | 32,052,000.00 | N/A | 32,516,000.00 |
| Interest Paid Classified As Financing Activities | 6,639,000.00 | N/A | 5,970,000.00 | N/A | 7,305,000.00 |
| Cash Flows From Used In Financing Activities | -53,933,000.00 | N/A | 27,858,000.00 | N/A | -43,113,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 9,553,000.00 | N/A | 56,929,000.00 | N/A | -51,317,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 0.00 | N/A | 0.00 | N/A | 0.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 9,553,000.00 | N/A | 56,929,000.00 | N/A | -51,317,000.00 |
| Cash and cash equivalents | 17,840,000.00 | 8,287,000.00 | 74,769,000.00 | 17,840,000.00 | 23,452,000.00 |
Please note that some sums might not add up.
PLENLMD00017
LEI259400C3GI6IVAOIM347
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.